01 7Lunesta
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 125
2019 Revenue in Millions : 117
Growth (%) : 7
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 79
2020 Revenue in Millions : 120
Growth (%) : -30
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 8
2021 Revenue in Millions : 79
Growth (%) : -89
Main Therapeutic Indication : Sleep Disorders
Currency : USD
2016 Revenue in Millions : 2
2015 Revenue in Millions : 50
Growth (%) : -96
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 95
2016 Revenue in Millions : 72
Growth (%) : 32
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 99
2017 Revenue in Millions : 89
Growth (%) : 11%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 113
2018 Revenue in Millions : 102
Growth (%) : 11
LOOKING FOR A SUPPLIER?